Ruth Lathi, MD
Academic Appointments
- Assistant Professor - Med Center Line, Obstetrics & Gynecology - Reproductive Endocrinology & Infertility
Key Documents
Contact Information
-
Clinical Offices
900 Welch Road, Suite 350 MC 5762 Palo Alto, CA 94304 Tel Work (650) 498-7911 Fax (650) 498-7294
- Academic Offices
Personal Information Email Tel (650) 498-7911Alternate Contact Tracy Lindsay Administrative Assistant Email Tel Work 650-498-7408Not for medical emergencies or patient use
Professional Overview
Clinical Focus
- Fertility (Reproductive Medicine)
- Recurrent Pregnancy Loss and Miscarriage
- Gynecology
- Reprod. Endocrinology and Infertility
Administrative Appointments
- Director, Recurrent Pregnancy Loss Program, Reproductive Endocrinology & Infertilty Division, Stanford University (2007 - present)
- Associate Director of the REI fellowship, Stanford University (2004 - present)
Honors and Awards
- CREOG - Faculty Teaching Award, Stanford University Medical Center, Department of Obstetrics and Gynecology (2006)
Professional Education
| Residency: | Baylor College of Medicine TX (2000) |
| Fellowship: | Stanford Hospital and Clinics CA (2003) |
| Board Certification: | Reprod. Endocrinology and Infertility, American Board of Obstetrics and Gynecology (2006) |
| Board Certification: | Obstetrics and Gynecology, American Board of Obstetrics and Gynecology (2005) |
| Internship: | Baylor College of Medicine TX (1997) |
| Medical Education: | UCSF Medical Center CA (1996) |
Graduate & Fellowship Program Affiliations
Internet Links
Scientific Focus
Current Research Interests
Pregnancies after infertility: prospectively collecting serum and consent for outcomes research in all women with history of infertility or recurrent miscarriage. Planned projects include evaluation of testosterone levels in relationship to fertility treatments, prospective study on pregnancy outcomes of women with PCOS compared to other women undergoing fertility treatments, miscarriage rates with different diagnoses and treatments.
Karyotypes of miscarriages: collecting karyotype information, ultrasound findings and clinical characteristics on patients miscarrying undergoing D&Cs. Over 350 karyotypes already entered. Objective: to evaluate subsequent pregnancy outcomes and utility of workup for recurrent pregnancy loss in setting of normal and abnormal karyotypes.
Unexplained recurrent pregnancy loss and immune changes. Objective: analyzing peripheral blood and RNA by micro array analysis in women with and without unexplained recurrent pregnancy loss during the luteal phase of the menstrual and early pregnancy.
Publications
- Frequency of the male infertility evaluation: data from the national survey of family growth. J Urol. 2013; (3): 1030-4
- Comparison of morbidity associated with laparoscopic myomectomy and hysterectomy for the treatment of uterine leiomyomas. J Obstet Gynaecol Can. 2012; (1): 57-62
- Early pregnancy testosterone after ovarian stimulation and pregnancy outcome. Fertil Steril. 2012; (1): 23-7.e1
- Informatics enhanced SNP microarray analysis of 30 miscarriage samples compared to routine cytogenetics. PLoS One. 2012; (3): e31282
- Oocyte retrieval following continued stimulation five days beyond ovulation yields live birth after frozen embryo transfer. J Assist Reprod Genet. 2012; (5): 433-5
- Outcomes of trophectoderm biopsy on cryopreserved blastocysts: a case series. Reprod Biomed Online. 2012; (5): 504-7
Help